Zhenzhou He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhenzhou He has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Hui Li
Ren Ji Hospital (South Campus),School of Medicine,Shanghai Jiaotong University
3 shared publicationsHui Wu
Ren Ji Hospital,School of Medicine,Shanghai Jiaotong University
3 shared publicationsJiajia Tang
Ren Ji Hospital (South Campus),School of Medicine,Shanghai Jiaotong University
3 shared publicationsShuya Mei
Ren Ji Hospital (South Campus),School of Medicine,Shanghai Jiaotong University
3 shared publicationsTianyi Ai
Ren Ji Hospital (South Campus),School of Medicine,Shanghai Jiaotong University
3 shared publicationsZhiqiang Shi
Ren Ji Hospital (South Campus),School of Medicine,Shanghai Jiaotong Universtiy
3 shared publications
Latest Publications
- 20 May 2026
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 90 (8) , 1044-1054
Thymol gel ameliorates anesthesia-related postoperative neuropathic pain: Modulation of inflammatory mediators in a rat model
This study investigated the molecular mechanisms and therapeutic efficacy of chitosan-based thymol gels (2.5%, 5%, and 10%) in postoperative neuropathic pain. Gels exhibited pseudoplastic shear-thinning behavior and a biphasic release profile, achieving > 90% cumulative release within 12 h. Using a Wistar rat model of hind paw incision, topical treatment with 5% and 10% thymol gels significantly (p < 0.05) reversed the reduction in paw withdrawal latency and threshold compared to the controls. Thymol gel markedly decreased serum corticosterone, cyclooxygenase-2 (COX-II), and prostaglandin E2 (PGE2) levels. Furthermore, it downregulated the messenger ribonucleic acid (mRNA) expression of interleukins and tumor necrosis factor in the sciatic nerve. Histopathological analysis confirmed reduced inflammation and congestion. Positive correlations were observed between pro-inflammatory cytokine expression and serum corticosterone, PGE2, and COX-II levels. These findings suggest that thymol gel effectively ameliorates anesthesia-related postoperative neuropathic pain by modulating key inflammatory mediators, suggesting its beneficial treatment option for alleviating such pain.
- 20 May 2026
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 90 (8) , 1044-1054
Thymol gel ameliorates anesthesia-related postoperative neuropathic pain: Modulation of inflammatory mediators in a rat model
This study investigated the molecular mechanisms and therapeutic efficacy of chitosan-based thymol gels (2.5%, 5%, and 10%) in postoperative neuropathic pain. Gels exhibited pseudoplastic shear-thinning behavior and a biphasic release profile, achieving > 90% cumulative release within 12 h. Using a Wistar rat model of hind paw incision, topical treatment with 5% and 10% thymol gels significantly (p < 0.05) reversed the reduction in paw withdrawal latency and threshold compared to the controls. Thymol gel markedly decreased serum corticosterone, cyclooxygenase-2 (COX-II), and prostaglandin E2 (PGE2) levels. Furthermore, it downregulated the messenger ribonucleic acid (mRNA) expression of interleukins and tumor necrosis factor in the sciatic nerve. Histopathological analysis confirmed reduced inflammation and congestion. Positive correlations were observed between pro-inflammatory cytokine expression and serum corticosterone, PGE2, and COX-II levels. These findings suggest that thymol gel effectively ameliorates anesthesia-related postoperative neuropathic pain by modulating key inflammatory mediators, suggesting its beneficial treatment option for alleviating such pain.
- Open Access
- 8 November 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (11) , 113401
hnRNPA1 SUMOylation promotes cold hypersensitivity in chronic inflammatory pain by stabilizing TRPA1 mRNA
- 8 November 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (11) , 113401
Open AccesshnRNPA1 SUMOylation promotes cold hypersensitivity in chronic inflammatory pain by stabilizing TRPA1 mRNA
- RetractedOpen Access
- 1 December 2020
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 13, 3315-3329
Intraarticular Injection of Infliximab-Loaded Thermosensitive Hydrogel Alleviates Pain and Protects Cartilage in Rheumatoid Arthritis
Purpose: Pain and cartilage destruction caused by rheumatoid arthritis (RA) are major challenges during clinical treatment. Traditional systemic administration not only has obvious side effects but also provides limited relief for local symptoms in major joints. Local delivery of therapeutics for RA treatment is a potential strategy but is limited by rapid intraarticular release. Materials and Methods: In this study, we prepared a thermoresponsive injectable hydrogel by mixing pluronic F127 (F127) and hyaluronic acid (HA) with poly (γ-glutamic acid) (PGA) incorporating infliximab (IFX), a new generation monoclonal antibody drug. We investigated the biocompatibility of the hydrogel and its IFX release profile. In vivo, we studied the clinical manifestations (articular skin temperature and joint diameter), detected cytokines in the synovial fluid and cartilage, performed behavioral studies on pain relief, and evaluated the cartilage protection effect. Results: A thermoresponsive hydrogel was successfully prepared by mixing F127, HA, and PGA with injectable properties. The F127-HA-PGA hydrogel had a porous structure with interconnected pores. The infliximab-loaded thermosensitive hydrogel exhibited good biocompatibility and biodegradability and sustained release properties. Intraarticular injection of the IFX-loaded F127-HA-PGA hydrogel could alleviate the expression of inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and interleukin-17 (IL-17), in the synovial fluid and cartilage as well as relieve pain and inhibit cartilage destruction in RA. Conclusion: The double effect on pain relief and cartilage protection indicated the significant potential of the IFX-loaded injectable hydrogel for RA treatment in major joint lesions.
- 1 December 2020
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 13, 3315-3329
RetractedOpen AccessIntraarticular Injection of Infliximab-Loaded Thermosensitive Hydrogel Alleviates Pain and Protects Cartilage in Rheumatoid Arthritis
Purpose: Pain and cartilage destruction caused by rheumatoid arthritis (RA) are major challenges during clinical treatment. Traditional systemic administration not only has obvious side effects but also provides limited relief for local symptoms in major joints. Local delivery of therapeutics for RA treatment is a potential strategy but is limited by rapid intraarticular release. Materials and Methods: In this study, we prepared a thermoresponsive injectable hydrogel by mixing pluronic F127 (F127) and hyaluronic acid (HA) with poly (γ-glutamic acid) (PGA) incorporating infliximab (IFX), a new generation monoclonal antibody drug. We investigated the biocompatibility of the hydrogel and its IFX release profile. In vivo, we studied the clinical manifestations (articular skin temperature and joint diameter), detected cytokines in the synovial fluid and cartilage, performed behavioral studies on pain relief, and evaluated the cartilage protection effect. Results: A thermoresponsive hydrogel was successfully prepared by mixing F127, HA, and PGA with injectable properties. The F127-HA-PGA hydrogel had a porous structure with interconnected pores. The infliximab-loaded thermosensitive hydrogel exhibited good biocompatibility and biodegradability and sustained release properties. Intraarticular injection of the IFX-loaded F127-HA-PGA hydrogel could alleviate the expression of inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and interleukin-17 (IL-17), in the synovial fluid and cartilage as well as relieve pain and inhibit cartilage destruction in RA. Conclusion: The double effect on pain relief and cartilage protection indicated the significant potential of the IFX-loaded injectable hydrogel for RA treatment in major joint lesions.
- 1 March 2020
- Published by Elsevier in Microvascular Research
- Vol. 128, 103941
PEAR1 suppresses the proliferation of pulmonary microvascular endothelial cells via PI3K/AKT pathway in ALI model
- 1 March 2020
- Published by Elsevier in Microvascular Research
- Vol. 128, 103941
PEAR1 suppresses the proliferation of pulmonary microvascular endothelial cells via PI3K/AKT pathway in ALI model
- Open Access
- 14 January 2020
- Published by Springer Nature in BMC Neurology
- Vol. 20 (1) , 1-7
Association between NMD3 and symptoms of Parkinson’s disease in Chinese patients
Background: Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder that is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Large-scale meta-analyses of genome-wide association studies (GWAS) have identified few susceptibility loci in patients with sporadic PD. The aim of this study was to investigate the association between NMD3 single nucleotide polymorphism (SNP) and symptoms in PD patients in South China. Methods: A total of 217 PD patients were recruited in this study and genotyped by using the SNaPshot technique and the polymerase chain reaction. All subjects were evaluated by the Mini-Mental State Examination (MMSE), Beijing version Montreal Cognitive Assessment (MoCA), Sniffin’ Sticks 16 (SS-16), Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale, 39-item Parkinson’s Disease Questionnaire (PDQ-39) and MDS Unified PD Rating Scale (MDS-UPDRS). Results: NMD3 rs34016896 (C > T) carriers have worse cognitive function than wild types (MMSE: p = 0.042, NMD3 wild type: 27.44 ± 2.89, NMD3 carriers: 26.31 ± 3.79; MoCA: p = 0.005, NMD3 wild type: 23.15 ± 4.20, NMD3 carriers: 20.75 ± 6.68). Conclusions: The recessive and overdominant model of NMD3 rs34016896 was associated with cognitive impairment in PD patients.
- 14 January 2020
- Published by Springer Nature in BMC Neurology
- Vol. 20 (1) , 1-7
Open AccessAssociation between NMD3 and symptoms of Parkinson’s disease in Chinese patients
Background: Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder that is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Large-scale meta-analyses of genome-wide association studies (GWAS) have identified few susceptibility loci in patients with sporadic PD. The aim of this study was to investigate the association between NMD3 single nucleotide polymorphism (SNP) and symptoms in PD patients in South China. Methods: A total of 217 PD patients were recruited in this study and genotyped by using the SNaPshot technique and the polymerase chain reaction. All subjects were evaluated by the Mini-Mental State Examination (MMSE), Beijing version Montreal Cognitive Assessment (MoCA), Sniffin’ Sticks 16 (SS-16), Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale, 39-item Parkinson’s Disease Questionnaire (PDQ-39) and MDS Unified PD Rating Scale (MDS-UPDRS). Results: NMD3 rs34016896 (C > T) carriers have worse cognitive function than wild types (MMSE: p = 0.042, NMD3 wild type: 27.44 ± 2.89, NMD3 carriers: 26.31 ± 3.79; MoCA: p = 0.005, NMD3 wild type: 23.15 ± 4.20, NMD3 carriers: 20.75 ± 6.68). Conclusions: The recessive and overdominant model of NMD3 rs34016896 was associated with cognitive impairment in PD patients.
- 1 December 2019
- Published by Elsevier in Experimental Neurology
- Vol. 322, 113045
Salvinorin A moderates postischemic brain injury by preserving endothelial mitochondrial function via AMPK/Mfn2 activation
- 1 December 2019
- Published by Elsevier in Experimental Neurology
- Vol. 322, 113045
Salvinorin A moderates postischemic brain injury by preserving endothelial mitochondrial function via AMPK/Mfn2 activation
- Open Access
- 7 November 2019
- Published by Springer Nature in Research Square
Association between NMD3 and symptoms of Parkinson's disease in Chinese
Bcakground: Parkinson's disease (PD) is a progresasive neurodegenerative movement disorder which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Large-scale meta-analyses of genome-wide association studies (GWAS) have identified few susceptibility loci in sporadic PD. The aim of this study was to investigate the association between NMD3 single nucleotide polymorphism (SNP) and symptoms of PD patients in southern Chinese. Methods: A total of 217 PD patients were recruited in this study and were genotyped by using SNaPshot technique and the polymer chain reaction. All subjects were evaluated by Mini-Mental State Examination (MMSE), Beijing version Montreal Cognitive Assessment (MoCA), Sniffin’ Sticks 16 (SS-16), Hamilton anxiety rating scale, Hamilton depression rating scale, 39-item Parkinson's disease Questionnaire (PDQ-39) and MDS Unified PD Rating Scale (MDS-UPDRS). Results: NMD3 rs34016896 (T) carriers have worse cognitive function (MMSE: p 0.042, NMD3wildtype: 27.44 ± 2.89, NMD3 carriers: 26.31 ± 3.79; MoCA: p 0.005, NMD3 wildtype: 23.15 ±4.20, NMD3 carriers: 20.75 ± 6.68). Conclusions: The recessive and overdominant model of NMD3 rs34016896 was associated with cognitive impairment in PD patients.
- 7 November 2019
- Published by Springer Nature in Research Square
Open AccessAssociation between NMD3 and symptoms of Parkinson's disease in Chinese
Bcakground: Parkinson's disease (PD) is a progresasive neurodegenerative movement disorder which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Large-scale meta-analyses of genome-wide association studies (GWAS) have identified few susceptibility loci in sporadic PD. The aim of this study was to investigate the association between NMD3 single nucleotide polymorphism (SNP) and symptoms of PD patients in southern Chinese. Methods: A total of 217 PD patients were recruited in this study and were genotyped by using SNaPshot technique and the polymer chain reaction. All subjects were evaluated by Mini-Mental State Examination (MMSE), Beijing version Montreal Cognitive Assessment (MoCA), Sniffin’ Sticks 16 (SS-16), Hamilton anxiety rating scale, Hamilton depression rating scale, 39-item Parkinson's disease Questionnaire (PDQ-39) and MDS Unified PD Rating Scale (MDS-UPDRS). Results: NMD3 rs34016896 (T) carriers have worse cognitive function (MMSE: p 0.042, NMD3wildtype: 27.44 ± 2.89, NMD3 carriers: 26.31 ± 3.79; MoCA: p 0.005, NMD3 wildtype: 23.15 ±4.20, NMD3 carriers: 20.75 ± 6.68). Conclusions: The recessive and overdominant model of NMD3 rs34016896 was associated with cognitive impairment in PD patients.
- Open Access
- 14 October 2019
- Published by Springer Nature in Research Square
Association between NMD3 and symptoms of Parkinson’s disease in Chinese
Bcakground Parkinson's disease (PD) is a progressive degenerative disorder of the basal ganglia that not only affects the initiation and execution of voluntary movements, but also nonmotor features. The aim was to investigate the association between NMD3 and symptoms of PD patients in Chinese. Methods 217 PD patients were recruited in this study. All patients were evaluated by Sniffin’ Sticks 16 (SS-16), Hamilton anxiety rating scale and Hamilton depression rating scale, 39-item Parkinson's disease Questionnaire (PDQ-39) and MDS - Unified PD Rating Scale (MDS-UPDRS). Symptoms were also recorded. Results NMD3 carriers had worse cognitive function (MMSE: p 0.042, NMD3 wildtype: 27.44 ± 2.89, NMD3 carriers: 26.31 ± 3.79; MoCA: p 0.005, NMD3 wildtype: 23.15 ± 4.20, NMD3 carriers: 20.75 ± 6.68). Conclusions The recessive and overdominant model of GALC rs8001572 was associated with the presence of sensitive to light.
- 14 October 2019
- Published by Springer Nature in Research Square
Open AccessAssociation between NMD3 and symptoms of Parkinson’s disease in Chinese
Bcakground Parkinson's disease (PD) is a progressive degenerative disorder of the basal ganglia that not only affects the initiation and execution of voluntary movements, but also nonmotor features. The aim was to investigate the association between NMD3 and symptoms of PD patients in Chinese. Methods 217 PD patients were recruited in this study. All patients were evaluated by Sniffin’ Sticks 16 (SS-16), Hamilton anxiety rating scale and Hamilton depression rating scale, 39-item Parkinson's disease Questionnaire (PDQ-39) and MDS - Unified PD Rating Scale (MDS-UPDRS). Symptoms were also recorded. Results NMD3 carriers had worse cognitive function (MMSE: p 0.042, NMD3 wildtype: 27.44 ± 2.89, NMD3 carriers: 26.31 ± 3.79; MoCA: p 0.005, NMD3 wildtype: 23.15 ± 4.20, NMD3 carriers: 20.75 ± 6.68). Conclusions The recessive and overdominant model of GALC rs8001572 was associated with the presence of sensitive to light.
- Open Access
- 3 June 2019
- Published by Springer Nature in Research Square
Association between NMD3 and symptoms of Parkinson’s disease in Chinese
Bcakground Parkinson's disease (PD) is a progressive degenerative disorder of the basal ganglia that not only affects the initiation and execution of voluntary movements, but also nonmotor features. The aim was to investigate the association between NMD3 and symptoms of PD patients in Chinese. Methods 217 PD patients were recruited in this study. All patients were evaluated by Sniffin’ Sticks 16 (SS-16), Hamilton anxiety rating scale and Hamilton depression rating scale, 39-item Parkinson's disease Questionnaire (PDQ-39) and MDS - Unified PD Rating Scale (MDS-UPDRS). Symptoms were also recorded. Results NMD3 carriers had worse cognitive function (MMSE: p 0.042, NMD3 wildtype: 27.44 ± 2.89, NMD3 carriers: 26.31 ± 3.79; MoCA: p 0.005, NMD3 wildtype: 23.15 ± 4.20, NMD3 carriers: 20.75 ± 6.68). Conclusions The recessive and overdominant model of GALC rs8001572 was associated with the presence of sensitive to light.
- 3 June 2019
- Published by Springer Nature in Research Square
Open AccessAssociation between NMD3 and symptoms of Parkinson’s disease in Chinese
Bcakground Parkinson's disease (PD) is a progressive degenerative disorder of the basal ganglia that not only affects the initiation and execution of voluntary movements, but also nonmotor features. The aim was to investigate the association between NMD3 and symptoms of PD patients in Chinese. Methods 217 PD patients were recruited in this study. All patients were evaluated by Sniffin’ Sticks 16 (SS-16), Hamilton anxiety rating scale and Hamilton depression rating scale, 39-item Parkinson's disease Questionnaire (PDQ-39) and MDS - Unified PD Rating Scale (MDS-UPDRS). Symptoms were also recorded. Results NMD3 carriers had worse cognitive function (MMSE: p 0.042, NMD3 wildtype: 27.44 ± 2.89, NMD3 carriers: 26.31 ± 3.79; MoCA: p 0.005, NMD3 wildtype: 23.15 ± 4.20, NMD3 carriers: 20.75 ± 6.68). Conclusions The recessive and overdominant model of GALC rs8001572 was associated with the presence of sensitive to light.